## Note
nid: 1522345452289
model: AnKingOverhaul
tags: #AK_Original_Decks::Step_1::Zanki_Pharmacology, #AK_Step1_v11::#FirstAid::05_Pharmacology::02_Autonomic_Drugs::06_Cholinomimetic_Agents::Indirect_Agonists::Neuromuscular_Junction_Blockage, #AK_Step1_v11::#FirstAid::05_Pharmacology::02_Autonomic_Drugs::06_Cholinomimetic_Agents::Indirect_Agonists::Neuromuscular_Junction_Blockage::Depolarizing, #AK_Step1_v11::#FirstAid::12_Neuro_&_Special_Senses::06_Pharm::16_Neuromuscular_Blocking_Drugs, #AK_Step1_v11::#FirstAid::12_Neuro_&_Special_Senses::06_Pharm::16_Neuromuscular_Blocking_Drugs::Depolarizing, #AK_Step1_v11::#OME_banner, #AK_Step1_v11::#Physeo::09_Pharm::14_Neuro::19_Neuromuscular_Blocking_Drugs, #AK_Step1_v11::#Pixorize::02_Biochem::20_Anesthetics::03_Succinylcholine, #AK_Step1_v11::#Pixorize::03_Pharm::14_Anesthetics::Succinylcholine, #AK_Step1_v11::#SketchyPharm::06_Neuro/Psych::FA-Neuro, #AK_Step1_v11::#UWorld::1000-9999::1000-1999::1212, #AK_Step1_v11::^Other::^EXPN::BGadd, #AK_Step1_v11::^Other::^EXPN::BGnonessentials, #AK_Step1_v11::^Other::^EXPN::Uworld, #AK_Step1_v11::^Other::^HighYield::4-LowerYield, #AK_Step1_v11::^Systems::Neuro::Pharmacology
markdown: false

### Text
During <b>phase II blockade</b> using <u>depolarizing</u> NMJ
blockers, TOF shows a(n) {{c1::progressive reduction}} in each of
the four responses

### Extra
aka "fading pattern", this is because persistent exposure to
succinylcholine results in ACh receptor desensitiziation and
inactivation (functionally similar to nondepolarizing blockade)
<div><img src="Succinylcholine%20.png"></div>

### Lecture Notes


### Missed Questions


### Pathoma


### Boards and Beyond


### First Aid


### Sketchy
#REF!

### Pixorize


### Physeo


### OME
<div class="ome-widget">
  <a href="https://onlinemeded.org?ref=anki"><img src=
  "_OME_AnkiFlashcards_General_4.png"></a>
</div>

### Additional Resources


### One by one

